VERA

$30.98-3.10%visit website

Vera Therapeutics, Inc.

Market Cap

$2.2B

Live price × SEC shares (Jul 29, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

0.99

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

5.5

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

N/M

TTM to Jun 2026 · negative EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Research & development	56,473	59,310	86,011	60,080	261,874
Total operating expenses	83,932	94,206	125,132	112,490	415,760
Operating income	(83,932)	(94,206)	(125,132)	(112,490)	(415,760)
Interest expense	1,960	1,904	1,823	1,848	7,535
Net income	(80,293)	(91,097)	(121,032)	(109,473)	(401,895)
EPS (basic) ($)	(1.26)		(1.69)	(1.52)	(5.87)
EPS (diluted) ($)	(1.26)		(1.69)	(1.52)	(5.87)
Weighted avg. shares (basic)	63,847		71,477	71,838
Weighted avg. shares (diluted)	63,847		71,477	71,838

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 10, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 22 more quarters, back to Mar 2020, with Tormere Pro.

Signals

purchases / sales, 90d

Short Volume

52%

W/W +12.4pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Velocity Score

1.73x

Avg Daily Selling (90d)

411 sh/day

Baseline Daily Selling

570 sh/day

Unique Sellers (90d)

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-09-15	2026-09-17	Fordyce Marshall	Director & PRESIDENT AND CEO	Sale	18.5K	$37.00	$685K	235.2K	View
2026-09-02	2026-09-04	Fordyce Marshall	Director & PRESIDENT AND CEO	Sale	18.5K	$35.12	$650K	235.2K	View
2026-07-07	2026-07-09	Fordyce Marshall	Director & PRESIDENT AND CEO	Sale	46.3K	$42.30	$1.96M	152.0K	View
2026-06-23	2026-06-24	Fordyce Marshall	Director & PRESIDENT AND CEO	Sale	18.5K	$37.93	$702K	198.2K	View
2026-05-12	2026-05-13	Fordyce Marshall	Director & PRESIDENT AND CEO	Sale	18.5K	$36.74	$680K	216.7K	View

1–5 of 13

1 / 3

Recent News

(VERA) Movement as an Input in Quant Signal Sets

Stock Traders Daily · 2026-11-04

Vera Therapeutics, Inc. (VERA) Stock Price, News, Quote & History

Yahoo! Finance Canada · 2026-11-03

Vera Therapeutics, Inc. (VERA) stock price, news, quote and history

Yahoo Finance Singapore · 2026-11-03

Vera Therapeutics to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference

Yahoo · 2026-11-02

Vera Therapeutics leaders will speak in Boston and meet investors.

Stock Titan · 2026-11-02

Vera Therapeutics (NasdaqGM:VERA) Stock Forecast & Analyst Predictions

Simply Wall St · 2026-10-30

Vera Therapeutics' TRUTAKNA Delivers Strong Phase III IgA Nephropathy Results

Yahoo · 2026-10-23

Vera Therapeutics Announces Positive ORIGIN 3 Final Efficacy Analysis of TRUTAKNA™ (atacicept-vymj) in IgA Nephropathy Presented at ASN Kidney Week 2026 and Published in the New England Journal of Medicine

Yahoo · 2026-10-22

Vera Therapeutics Announces Its ORIGIN 3 Study Of TRUTAKNA In Adults With Primary IgA Nephropathy Achieves Primary Endpoint Of Proteinuria Reduction At 36 Weeks

Benzinga · 2026-10-22

Nvidia announces plug and play Vera Rubin racks that can be shipped on a truck

CNBC · 2026-10-21

Vera Therapeutics to Host ASN Kidney Week Investor Webcast and Third Quarter 2026 Financial Results Conference Webcast

Yahoo · 2026-10-20

Leerink Partners Initiates Coverage On Vera Therapeutics with Market Perform Rating, Announces Price Target of $34

Benzinga · 2026-10-12

Alignment Healthcare, RenX Enterprises And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

Benzinga · 2026-10-09

Do Vera Therapeutics' (VERA) High-Profile IgAN Data Show Durable Moat or Crowded Mechanism Risk?

Yahoo · 2026-10-08

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Yahoo Finance · 2026-10-02

Informational purposes only, not investment advice.

Date	Insider	Type	Shares	Value
2026-09-15	Fordyce Marshall	S	18,500	$684,500
2026-09-02	Fordyce Marshall	S	18,500	$649,642.3
2026-07-07	Fordyce Marshall	S	1,000	$40,776.2
2026-07-07	Fordyce Marshall	S	2,200	$95,908.34
2026-07-07	Fordyce Marshall	S	10,500	$450,006.9

VERA

Financial Statements

Signals

Factor Profile

Recent News

Vera Therapeutics, Inc. (VERA)

Reporting Insiders

Factor Profile